Science & Technology
At mdxhealth, we use proprietary DNA-based technologies to innovate and create the next generation of breakthrough cancer diagnostics.
Research & Development
Our talented scientists are working in collaboration with academic and commercial agencies to accelerate the pace of innovation for cancer patients worldwide.
Our portfolio of diagnostic, prognostic, and predictive molecular assays is built on our patented methylation-specific PCR (MSP) technology.
Our products Select mdx and Confirm mdx provide actionable prostate cancer screening information and more confidence in the next clinical steps.
Clinical Research Network
Mdxhealth collaborates with a large number of international academic institutes, medical centers and organizations: